Fiocruz
no Portal
neste Site
Fundação Oswaldo Cruz
Página Principal

Áreas de PDI em Pesquisa em DST/Aids e Hepatites Virais 2008

 doi
doi
Araujo NM, Branco-Vieira M, Silva AC, Pilotto JH, Grinsztejn B, de Almeida AJ, Trepo C, Gomes SA. Occult hepatitis B virus infection in HIV-infected patients: Evaluation of biochemical, virological and molecular parameters. Hepatol Res. 2008 Jun 24.

 doi
doi
Bentancor GJB, Passaes CPB, Guimaraes ML, Lorete RS, Almeida SEM, Medeiros RM, Alencastro PR, Morgado MG. 2008. Origin and evolutionary history of HIV-1 subtype C in Brazil. AIDS 22: 1993-2000.

 doi
doi
Cuervo P, Cupolillo E, Britto C, González LJ, E Silva-Filho FC, Lopes LC, Domont GB, De Jesus JB. 2008. Differential soluble protein expression between Trichomonas vaginalis isolates exhibiting low and high virulence phenotypes. J Proteomics. 2008 Apr 30;71(1):109-22.

 doi
doi
Eyer-SilvaI WA, Couto-Fernandez JC; Silva-de-Jesus C; Morgado MG. 2008. Prevalence of HIV type 1 drug resistance mutations in treatment-naïve and experienced patients from resource-limited settings with universal access to antiretroviral therapy: a survey in two small Brazilian cities.Mem. Inst. Oswaldo Cruz;103(2):143-149, Mar.

 doi
doi
Gastaldello R, Mayo Iñiguez A, Otsuki K, Lamas G, Balangero M, Barbas MG, Mangano A, Sem L, Maturano E, Remondegui C, Paulo Vicente AC, Gallego S. HTLV type 1 genetic types among native descendants in Argentina. AIDS RESEARCH AND HUMAN RETROVIRUSESVolume 24, Number 9, 2008.

 doi
doi
Guimarães ML, Eyer-Silva WA, Couto-Fernandez JC, Morgado MG. Identification of two new CRF_BF in Rio de Janeiro State, Brazil. AIDS. 2008 Jan 30;22(3):433-5.

 doi
doi
Kratz JM, Andrighetti-Frohner CR, Kolling DJ, Leal PC; Cirne-Santos CC; Yunes RA; Nunes RJ; Trybala E; Bergström T; Frugulhetti ICPP, Barardi CRM; Simões CMO. Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate. Mem. Inst. Oswaldo Cruz, vol.103, no.5. Rio de Janeiro: Aug. 2008.

 Pubmed
Pubmed
Mirochnick M, Nielsen-Saines K, Pilotto JR, Pinto J, Jimenez E, Veloso VG, Parsons T, Watts H, Move J, Mofenson LM, Camarca M, Bryson Y, Morgado M, Yu E, Bethel J, Hawkins E, Smith E, Zwerski S, McDonough MD, Lancaster CT, PharoRuth C, Dickover RE, Kakehasi F, Ferreira F, Diniz L, Tavares M, Ribeiro JE, Gomes IM, Gouveia A.. Nevirapine concentrations in newborns receiving an extended prophylactic regimen. Jaids-Journal of acquired Immune Deficiency Syndromes Volume: 47, Issue: 3, Pages: 334-337, Published: MAR 1 2008.

 doi
doi
Malta M, Monteiro S, Jeronymo Lima RM, Bauken S, de Marco A, Zuim GC, Bastos FI, Singer M, Strathdee SA. 2008. HIV/AIDS risk among female sex workers who use crack in Southern Brazil. Rev. Saúde Pública vol.42 no.5 São Paulo

 doi
doi
Nicol AF, Nuovo GJ, Salomão-Estevez A, Grinsztejn B, Tristão A, Russomano F, Lapa E Silva JR, Oliveira MP, Pirmez C. Immune factors involved in the cervical immune response in the HIV/HPV co-infection. J Clin Pathol. 2008 Jan;61(1):84-8.

 doi
doi
Nicol AF, Pires ARC, de Souza SR, Nuovo GJ, Grinsztejn B, Tristão A, Russomano FB, Velasque L, Lapa e Silva JR, Pirmez C. Cell-cycle and suppressor proteins expression in uterine cervix in HIV/HPV co-infection: comparative study by tissue micro-array (TMA). BMC CANCER Volume: 8 Article Number: 289 Published: OCT 7 2008.

Souza TML, Cirne-Santos CC, Rodrigues DQ , Abreu CM, Tanuri A, Ferreira VF, Marques IP, de Souza MCBV, Fontes CFL, Frugulhetti ICDP, Bou-Habib DC. The compound 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid inhibits HIV-1 replication by targeting the enzyme reverse transcriptase. CURRENT HIV RESEARCH, Volume: 6, Issue: 3, Pages: 209-217, Published: MAY 2008.
Curr. HIV res.

Instituto Oswaldo Cruz /IOC /FIOCRUZ - Av. Brasil, 4365 - Tel: (21) 2598-4220 | INTRANET IOC| EXPEDIENTE
Manguinhos - Rio de Janeiro - RJ - Brasil CEP: 21040-360

Logos